Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Demographics and ipilimumab dose
| Number | Percent | |
|---|---|---|
| Age | 60 (median) | 21–75 (range) |
| Gender | ||
| Male | 20 | 61 |
| Female | 13 | 39 |
| Stage | ||
| III | 8 | 24 |
| IVa | 4 | 12 |
| IVb | 4 | 12 |
| IVc | 17 | 52 |
| Mutational status | ||
| BRAF | 8 | 24 |
| NRAS | 8 | 24 |
| CKIT | 1 | 3 |
| WT | 10 | 30 |
| Unknown | 6 | 18 |
| Prior therapy | ||
| Chemotherapy | 12 | 36 |
| IL-2 | 3 | 9 |
| Targeted therapy | 4 | 12 |
| Number of lines | 0–4 (range) | |
| Dose of ipilimumab | ||
| 3mg/kg | 20 | 61 |
| 10mg/kg | 8 | 24 |
| unknown | 5 | 15 |
| Indication | ||
| Metastatic, no brain mets | 18 | 55 |
| Metastatic, brain mets | 7 | 21 |
| Adjuvant | 8 | 24 |
